Brief: Venus Remedies Granted Market Authorization For Bleomycin 15,000 IU In UK
26/10/2023 05:15
Oct 26 (Reuters) - Venus Remedies Ltd VENR.NS :
* VENUS REMEDIES GRANTED MARKET AUTHORIZATION FOR BLEOMYCIN
15,000
IU IN UNITED KINGDOM
Source text for Eikon: ID:nBSE6gNbf7
Further company coverage: VENR.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage